Shahid Insaf
Psychiatry · Branson, MONPI 1174666044
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by Axsome Therapeutics, Inc. at 28.9% of the total. 2025 is the largest year on record at $172,074, 6.4 times the $26,767 reported in 2019. Among psychiatry clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,368 payments — averaging $303.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$120K
- Alkermes, Inc.$115K
- Supernus Pharmaceuticals, Inc.$77K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$52K
- AbbVie$33K
- Teva Pharmaceuticals USA, Inc.$3K
- plus $15K from 35 others
What the payments were for
- Consulting fees$69,84317%
- Speaking & faculty fees$248,66760%
- Travel & lodging$68,85017%
- Food & beverage$27,8647%
- Education$4880%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$415,711 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 17 | $193,947 |
| AuvelityDextromethorphan Hbr/Bupropion | 105 | $104,303 |
| AristadaAripiprazole Lauroxil | 23 | $60,028 |
| NuedextaDextromethorphan Hbr/Quinidine | 25 | $38,541 |
| TrintellixVortioxetine Hydrobromide | 63 | $36,991 |
| FanaptIloperidone | 24 | $34,316 |
| RexultiBrexpiprazole | 20 | $28,447 |
| DayvigoLemborexant | 38 | $12,214 |
| VyvanseLisdexamfetamine Dimesylate | 22 | $8,354 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 29 | $6,501 |
| AzstarysSerdexmethylphen/Dexmethylphen | 12 | $4,781 |
| Tranylcypromine Sulfate | 16 | $2,902 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 30 | $2,395 |
| Naltrexone Hcl | 30 | $1,960 |
| Propranolol Hcl ErPropranolol Hcl | 57 | $1,490 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,639 | $193,94717 claims |
| Axsome Therapeutics, Inc.Auvelity | $120,155 | $104,303105 claims |
| Alkermes, Inc.Aristada | $114,822 | $60,02823 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $497 | $45,34585 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $141 | $38,54125 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $1,707 | $34,31624 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,589 | $28,44720 claims |
| Eisai Inc.Dayvigo | $228 | $12,21438 claims |
| Corium, LLCAzstarys | $803 | $4,78112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 680 psychiatry providers in Missouri.
Other psychiatry in Branson
- Gregory MattingleySaint Charles$4.7M
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mohd MalikSaint Louis$956K
- Brian BarashKansas City$856K
- Casey ProughLees Summit$615K
- George GrossbergSaint Louis$501K
- Ahmed TaranissiMexico$343K
- Ravdeep KhanujaPoplar Bluff$310K
- Christopher LoyndSaint Louis$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.